Aetna CEO Bertolini on Obamacare Losses

The transcript discusses challenges faced by a company in the Affordable Care Act (ACA) marketplace, highlighting significant financial losses due to high specialty pharmacy use and inadequate risk adjustment mechanisms. The company is halting expansion plans and evaluating current markets to mitigate risks. While considering market exits, the company emphasizes the importance of individual markets and the need to protect its balance sheet. The discussion also touches on a DOJ lawsuit related to a proposed merger with Humana, focusing on its implications for the company's financial strategy.

What were the main reasons for the $200 million loss in the public exchanges during the second quarter?

How does the mechanism of risk adjustment in the exchanges affect the losses mentioned?

What factors are being evaluated to determine which markets to stay in or leave?

How does the potential merger with Humana relate to the company's current market strategy?

What is the significance of the balance sheet discussion in relation to the company's future decisions?